A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

August 22, 2024

Study Completion Date

January 9, 2025

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

SAR442970

1 mL extractable volume of 150 mg/mL SAR442970 filled in 2 mL glass vial

DRUG

Placebo

1 mL extractable volume of placebo filled in 2 mL glass vial

Trial Locations (50)

1200

Investigational Site Number : 0560002, Woluwe-Saint-Lambert

2145

Investigational Site Number : 0360005, Westmead

2170

Investigational Site Number : 0360002, Liverpool

3000

Investigational Site Number : 0560001, Leuven

3053

Investigational Site Number : 0360001, Carlton

4000

Investigational Site Number : 2080001, Roskilde

4102

Investigational Site Number : 0360003, Woolloongabba

10034

Investigational Site Number : 2030001, Prague

10117

Investigational Site Number : 2760005, Berlin

12462

Investigational Site Number : 3000003, Athens

14004

Investigational Site Number : 7240005, Córdoba

15006

Investigational Site Number : 2030002, Praha 5 - Motol

16121

Investigational Site Number : 3000001, Athens

20089

Investigational Site Number : 3800002, Rozzano

20122

Investigational Site Number : 3800001, Milan

28007

Investigational Site Number : 7240001, Madrid / Madrid

28046

Investigational Site Number : 7240006, Madrid

30328

Advanced Medical Research PC Site Number : 8400002, Sandy Springs

33613

ForCare Clinical Research Site Number : 8400006, Tampa

34470

Renstar Medical Research Site Number : 8400011, Ocala

44791

Investigational Site Number : 2760008, Bochum

46940

Investigational Site Number : 7240004, Manises

48149

Investigational Site Number : 2760001, Münster

51100

Investigational Site Number : 2500003, Reims

55131

Investigational Site Number : 2760004, Mainz

60590

Investigational Site Number : 2760002, Frankfurt am Main

69003

Investigational Site Number : 2500001, Lyon

70852

Investigational Site Number : 2030003, Ostrava - Poruba

77004

Center for Clinical Studies, LTD. LLP Site Number : 8400003, Houston

85006

Medical Dermatology Specialists Site Number : 8400007, Phoenix

90265

Investigational Site Number : 6160004, Lodz

94163

Investigational Site Number : 2500004, Saint-Mandé

95123

Investigational Site Number : 3800003, Catania

7580206

Investigational Site Number : 1520003, Santiago

7640881

Investigational Site Number : 1520001, Santiago

8420383

Investigational Site Number : 1520002, Santiago

02919

Clinical Partners, LLC Site Number : 8400010, Johnston

L4M 7G1

Investigational Site Number : 1240001, Barrie

N6H 5L5

Investigational Site Number : 1240002, London

L3Y 5G8

Investigational Site Number : 1240004, Newmarket

G1V 4T3

Investigational Site Number : 1240007, Québec

06200

Investigational Site Number : 2500002, Nice

4818 CK

Investigational Site Number : 5280002, Breda

9713 GZ

Investigational Site Number : 5280001, Groningen

3015 GD

Investigational Site Number : 5280003, Rotterdam

02-507

Investigational Site Number : 6160001, Warsaw

50-566

Investigational Site Number : 6160003, Wroclaw

51-685

Investigational Site Number : 6160002, Wroclaw

08041

Investigational Site Number : 7240003, Barcelona

125 44

Investigational Site Number : 7520001, Älvsjö

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY